SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (11057)7/9/1998 11:18:00 PM
From: Early Out  Read Replies (3) of 23519
 
Vlad:

This is from one of the VVUS press releases of today:

Vivus, (VVUS), attributed the loss to "the commercial U.S. launch of Viagra"

This is from one of the PFE press releases of today:

Pfizer plans to sell Viagra in 50 countries by the end of the year, assuming approval by European regulatory agencies.

This is from one of the VVUS press releases of next quarter:

Vivus, (VVUS), attributed the loss to "the international launch of Viagra"

It really is quite simple.

-jsc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News